Showing 1401-1410 of 20878 results for "".
- The Cellular Impact of Weight Loss on Surgical Risk Managementhttps://reachmd.com/news/the-cellular-impact-of-weight-loss-on-surgical-risk-management/2485294/A University of Southern Denmark report shows that substantial surgical and lifestyle-induced weight loss shifts adipose tissue toward a lean cellular profile—important because adipose
- Adenotonsillectomy in Pediatric Sleep-Disordered Breathing: A Shift Toward Surgical Intervention?https://reachmd.com/news/adenotonsillectomy-in-pediatric-sleep-disordered-breathing-a-shift-toward-surgical-intervention/2485266/Recent evidence shows that adenotonsillectomy improves growth and sleep-related outcomes in children with mild sleep-disordered breathing — a finding that coul
- Immune-Targeting Therapy with Aldesleukin: A New Frontier in Post-MI Carehttps://reachmd.com/news/immune-targeting-therapy-with-aldesleukin-a-new-frontier-in-post-mi-care/2485273/IVORY trials show low-dose aldesleukin after acute myocardial infarction reduced vascular inflammation by an average of nearly 8% on imaging and blood markers — a targeted signal in a defined post‑MI subgroup.
- Unpacking the Overhaul: Changes to the US Childhood Vaccine Schedule and Their Clinical Implicationshttps://reachmd.com/news/unpacking-the-overhaul-changes-to-the-us-childhood-vaccine-schedule-and-their-clinical-implications/2485265/HHS announced a major revision to the federal childhood immunization schedule: universal recommen
- Emerging Innovations in Cellular and Antibody Immunotherapies: Cancer Treatment Redefinedhttps://reachmd.com/news/emerging-innovations-in-cellular-and-antibody-immunotherapies-cancer-treatment-redefined/2485282/Bispecific CAR T cells targeting BCMA and BAFF‑R offer a two‑pronged cytotoxic strategy that may prevent relapse from single‑antigen loss in relapsed/refractory multiple myeloma—an approach with immediate translational relevance where single‑antigen therapies have failed.</
- Inflammation and Clinical Impact in Long COVID: Emerging Insightshttps://reachmd.com/news/inflammation-and-clinical-impact-in-long-covid-emerging-insights/2485269/Emerging evidence links persistent inflammation and circulating micro‑clots to multisystem Long COVID morbidity, offering a plausible biological pa
- Immunonutrition in Ulcerative Colitis: A Preclinical Study of Arginine, Glutamine, and HMBhttps://reachmd.com/news/immunonutrition-in-ulcerative-colitis-a-preclinical-study-of-arginine-glutamine-and-hmb/2485271/In a single DSS-induced rat study, oral supplementation with arginine, glutamine, and HMB produced greater histopathological improvement and broader redu
- Microbiome and Dietary Interventions in Infection Managementhttps://reachmd.com/news/microbiome-and-dietary-interventions-in-infection-management/2485278/High-protein diets markedly reduced Vibrio cholerae intestinal colonization in a recent preclinical model
- Enhancing Pediatric Emergency Triage and Analgesic Management: New Insights and Evolving Practiceshttps://reachmd.com/news/enhancing-pediatric-emergency-triage-and-analgesic-management-new-insights-and-evolving-practices/2485277/ICASS demonstrates superior sensitivity for identifying children likely to require pediatric trauma-center resources, supporting a practice-ready shift in how undertriage
- Analysis: Ustekinumab, IL-23 Inhibitors Show Higher Drug Survival in Psoriasishttps://reachmd.com/news/analysis-ustekinumab-il-23-inhibitors-show-higher-drug-survival-in-psoriasis/2485295/A new Danish cohort study using data from the DERMBIO registry suggests ustekinumab was linked with the best 5-year survival of comparators in bionaive patients with psoriasis. The analysis included a total of 7,193 treatment